**6. References**


Neutral Liposomes and DNA Transfection 343

Dimitriadis, G.J. (1978). Entrapment of ribonucleic acid in liposomes. *FEBS Lett*., 86, 289-293,

Dimitriadis, G.J. & Butters, T.D. (1979). Liposome-mediated ricin toxicity in ricin-resistant

Düzgünes, N., Wilschut, J., Fraley, R. & Papahadjopoulos, D. 1981. Studies on the

Edelstein, M.J., Abedi, M.R., Wicson, J. & Edelstein, M.R. (2004): Gene therapy clinical trials

Elouahabi, A. & Ruysschaert, J.M. (2005). Formation and intracellular trafficking of

Farhood, H., Serbina, N. & Huang, L. (1995), The role of dioleyl phosphatidylethaloamine in

Fasbender, A., Marshall, J., Moninger, T.O., Grust, T., Cheng, S. & Welsh, M.J. (1997).

Felgner, P.L., Gadek,T.R., Holm, M., Roman, R., Chan, H.W., Wenz, M., Northrop, J.P.,

Felgner, J.H., R Kumar, C N Sridhar, C J Wheeler, Y J Tsai, R Border, P Ramsey, M Martin, &

series of cationic lipid formulations. *J. Biol. Chem*., 269, 2550-2561, 0021-9258. Filion, M.C., Phillips, N.C. (1998). Major limitations in the use of cationic liposomes for

Finkelstein, M. & Weissmann, G. (1978). The introduction of enzymes into cells by means of

Fletcher S., Ahmad, A., Perouzel, E., Jorgensen & M.R., Miller, A.D. (2006). A dialkynoyl

Foradada, M.; Pujol, M.D.; Bermudez, J. & Esterlich, J. (2000). Chemical degradation of

Fraley, R., Subramani, S., Berg, P. & Papahadjopoulos, D. (1980). Introduction of liposomeencapsulated SV40 DNA into cells. *J. Biol. Chem*., 255, 10431-10435, 0021-9258. Fraley, R., Straubinger, R.M., Rule, G., Springer, A.L. & Papahadjopoulos, D. (1981).

Francescangeli, O.; Rinaldi, D.; Laus, M.; Galli, G. & Gallot, B.J. (1996). An X-ray study of a smectic C and smectic A liquid crystal polyacrylate. *J. Phys. II*, 6, 77-89. Francescangeli, O., Pisani, M., Stanic, V., Bruni, P. & Iacussi, M. (2003). Supramolecular

worldwide 1989-2004. *J. Genet. Med*., 6, 597-602, 1226-1769.

DANN delivery. *Int. J. Pharm*., 162, 159-170, 0378-5143.

liposomes. *J. Lip. Res*., 19, 289-303, 0022-2275.

*Biomol. Chem*., 4, 196-199, 1477-0520.

*Macromol. Res*., 7, 247-263, 81-271-0025-0.

lipoplexes and polyplexes. *Mol. Ther*., 11, 336-347, 1525-0016.

mechanism of membrane fusion. Role of head-group composition in calcium- and magnesium-induced fusion of mixed phospholipid vesicles. *Biochim. Biophys. Acta*,

cationic liposome- mediated gene transfer. *Biochim. Biophys. Acta*, 1235, 289-295,

Effect of co-lipids in enhancing cationic-lipid mediated gene transfer in vitro and in

Ringold, G.M. & Danielsen, M. (1987). Lipofection: A highly efficient, lipidmediated DNA-transfection procedure. *Proc. Natl. Acad. Sci. USA*, 84, 7413-7417,

P L Felgner. (1994). Enhanced gene delivery and mechanism studies with a novel

analog of DOPE improves gene transfer of lower-charged cationic lipoplexes. *Org.* 

liposomes by serum components detected by NMR. *Chem. Phys. Lipids*, 104, 133-148,

Liposome-mediated delivery of deoxyribonucleic acid to cells: enhanced efficiency of delivery related to lipid composition and incubation conditions. *Biochemistry*, 20,

ordering of self-assembled liposome-DNA- metal complexes. *Recent Res. Dev.* 

0014-5793.

0005-2736.

0027-8424.

0009-3084.

6978-6987, 0006-2960.

cells. *FEBS Lett*., 98, 33-36, 0014-5793.

vivo. *Gen. Ther*., 4, 716-725, 0969-7128.

642, 182-195, 0005-2736.


Boado R.J. (2007). Blood-brain barrier transport of non-viral gene and RNAi therapeutics.

Boukhnikachvili. T., Aguerre-Chariol, O., Airlau, M., Lesieur, S., Ollivon, M: & Vacus, J.

Boussif, O., Lezoualch, F., Zanta, M. A.,. Mergny, M. D., Scherman, D., Demeneix, B.J. &

Boussif, O., Gaucheron, J., Boulanger, C., Santaella, C., Kolbe, H.V.J. & Vierling, P. (2001).

Bruni, P.; Pisani, M.; Amici, A.; Marchini, C.; Montani, M. & Francescangeli, O. (2006). Self-

Budker, V. G., Kazatchkov, Y. A. & Naumova, L. P. (1978). Polynucleotides adsorb on

Caminiti, R. & Rossi Albertini, V. (1999). The kinetics of phase transitions observed by energy-dispersive X-ray diffraction. *Int. Rev. Phys. Chem*., 18, 263-299, 0144-235X. Caminiti, R.; Caracciolo, G.; Pisani, M. & Bruni, P. (2005). Effect of hydration on the long-

dispersive X-ray diffraction. *Chem. Phys. Lett*., 409, 331-336, 0009-2614. Caracciolo, G.; Caminiti, R.; Pozzi, D.; Friello, M.; Boffi, F. & Congiu Castellano A. (2002).

dispersive X-ray diffraction. *Chem. Phys. Lett*., 397, 138-143, 0009-2614. Caracciolo, G. & Caminiti, R. (2005). Do DC-Chol/DOPE-DNA complexes really form an inverted hexagonal phase? *Chem. Phys. Lett*., 411, 327-332, 0009-2614. Chapman, C.J., Erdahl, W.L., Taylor, R.W. & Pfeiffer, D.R. (1990). Factors affecting solute

thermodynamic study by EDXD. *Chem*. *Phys. Lett*., 351, 222-228, 0009-2614. Caracciolo, G.; Sadun, C.; Caminiti, R.; Pisani, M.; Bruni, P. & Francescangeli, O. (2004).

Deamer, D.W. & Barchfield, G.L. (1982). Encapsulation of macromolecules by lipid vesicles under simulated prebiotic conditions. *J.Mol. Evol*., 18, 203-206, 0022-2844. Deshpande, M.C.; Davies, M.C.; Garnett, M.C.; Williams, P.M.; Armitage, D.; Bailey, L.;

(1997). Structure of in-serum transfecting DNA-cationic lipid complexes. *FEBS Lett*.,

Behr P. (1995). A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine *Proc. Natl. Acad. Sci. USA*, *92*, 7297-7301,

Enhanced in vitro and in vivo cationic lipid-mediated gene delivery with a fluorinated glycerophospho-ethanolamine. *J.Gen. Med*., 3, 109-114, 1099-498X. Bruni, P., Gobbi, G., Morgganti, G., Iacussi, M. &Maurelli E. (1997). Use and activity of

metals in biological systems. The interaction of bivalent metal cations with doublestranded polynucleotides and phospholipids. *Gazz. Chim. Ital*., 127, 513-517, 0016-

assembled ternary complexes of neutral liposomes, deoxyribonucleic acid and bivalent metal cations. Promising vectors for gene transfer? *Applied Physics Letters,*

mitochondrial and model lipid membranes in the presence of bivalent cations.

range order of lipid multilayers investigated by in situ time-resolved energy

Self-assembly of cationic liposomes-DNA complexes: a structural and

Structure of solid-supported lipid-DNA-metal complexes investigated by energy

entrapment in phospholipid vesicles prepared by the freeze-thaw extrusion method: a possible general method for improving the efficiency of entrapment*.* 

Vamvakaki, M.; Armes, S.P. & Stolnik, S. (2004): The effect of poly(ethylene glycol) molecular architecture on cellular interaction and uptake of DNA complexes. *J.* 

*Pharm. Res.,* 24, 1772-1787, 0724-8741.

409, 188-194, 0014-5793.

88, 73901, 1-3, 0003-6951.

*FEBS Lett*., 95, 143-146, 0014-5793.

*Chem. Phys. Lipids*, 55, 73-83, 0009-3084.

*Control. Release*, 97, 143–156, 0168-3659.

0027-8424.

5603.


Neutral Liposomes and DNA Transfection 345

Kovalenko D.V.; Shafei, R.A.; Zelenina, I.A.; Semenova, M.L.; Samuilova, O.V. & Zhdanov,

Koynova, R.; Tenchov, B. & Rapp, G. (1997). Low amounts of PEG-lipid induce cubic phase

Koynova, R., Wang, L., Tarahovsky, W. & McDonald, R.C. (2005). Lipid phase control of

Koynova, R., Wang, Li. & MacDonald, R.C. (2006). An intracellular lamellar-non lamellar

transfection agents. *Proc. Natl. Acad. Sci. USA*, 103, 14373-14378, 0027-8424. Lin, A.J., Slack, N.L., Ahmad, A., George, C.X., Samuel, C.E. & Safinya, C.R. (2003). Three-

Liu, F. & Huang, L. (2002). Development of non-viral vectors for systemic gene delivery. *J.* 

Lurquin, P.F. (1979). Entrapment of plasmid DNA by liposomes and their interactions with

Lv, H., Zhang, S., Wang,B., Cui, S. & Yan, J. (2006). Toxicity of cationic lipids and cationic

Magee, W., Talcott, M., Straub, S. & Vriend, D. (1976). A comparison of negatively and

McDonald, R.C., Ashley, G.W., Shida M.M., Rakhmanova, V.A., Tarahovsky, Y.S.,

McManus, J.J., Rädler, J.O. & Dawson, K.A. (2003). Does calcium turn a zwitterionic lipid

McManus, J.J., Rädler, J.O. & Dawson, K.A. (2003). Phase behavior of DPPC in a DNA-

Mével, M., Neveu, C., Goncalves, C., Yaouanc, J.J., Pichon, C., Jaffrès, P.A. & Midoux, P.

Mok, K.W. & Cullis, P.R. (1997). Structural and fusogenic properties of cationic liposomes in

Monnard, P.A., Oberholzer, T. & Luisi, P.L. (1997). Entrapment of nucleic acids in

the presence of plasmid DNA. *Biophys. J*., 73, 2534-2545, 0006-3495.

liposomes. *Biochim. Biophys. Acta*, 1329, 39-50, 0005-2736.

positively charged liposomes containing entrapped polynosinic polycytidylic acid for interferon induction in mice. *Biochim. Biophys. Acta*, 451,610-618, 0304-4165.

Pantazatos, P.P., Kennedy, M.T., Pozharski, E.V., Baker, K.A., Jones, R.D., Rosenzweig, H.S., Choi, K.L., Qiu, R.Z. & McIntosh T. J. (1999). Physical and Biological Properties of cationic triesters of phosphatidylcholine*. Biophys. J*., 77,

calcium-zwitterionic lipid complex studied by small-angle x-ray scattering.

(2008). Novel neutral imidazole-lipophosphoramides for transfection assays*. Chem* 

mouse skeletal muscles in vivo. *Genetika*, *32*, 1299-1301, 1022-7954.

DNA delivery. *Bioconj. Chem*., 16, 1335-1339, 1043-1802.

plant protoplast. *Nucleic Acid Res*., 6, 3773-3784, 0305-1048. Luzzati, V. (1968). *Biological Membranes*, Academic Press, New York, London.

Marshall, E. (2000). Gene Therapy on Trial. *Science*, 288, 951-957, 0036-8075.

polymers in gene delivery. *J.Control. Rel*., 114, 100-109, 0168-5659.

*Biophys. J*., 84, 3307-3316, 0006-3495.

*Control. Rel*., 78, 259-266, 0168-3659.

2612-2629, 0006-3495.

9869-9875, 1520-6106.

cationic? *J. Phys. Chem. B*, 107,

*Comm*., 3124-3126, 1359-7345.

*Langmuir*, 19, 9630-9637, 0743-7463.

0005-2736.

R.I. (1996). Metallo nucleoliposome complexes as a vehicle for gene delivery to

in phosphatidylethanolamine dispersions. *Biochim. Biophys. Acta*, 1326, 167-170,

phase transition rationalizes the superior performance of some cationic lipid

dimensional imaging of lipid gene-carriers: membrane charge density controls universal transfection behavior in lamellar cationic liposome-DNA complexes


Francescangeli, O., Stanic, V., Gobbi, L., Bruni, P., Iacussi, M., Tosi, G. & Bernstorff, S. (2003).

Francescangeli, O.; Pisani, M.; Stanic, V.; Bruni, P. & Weiss, T.M. (2004). Evidence of an

Gaucheron, J., Santaella, C. & Vierling, P. (2001a). Higly fluorinated lipospermines fo gene

Gaucheron, J., Santaella, C. & Vierling, P. (2001b). Improved in vitro gene transfer mediated

Gaucheron, J., Boulanger, C., Santaella, C., Sbirrazzuoli, N., Boussif. O. & Vierling, P.

Gregoriadis, G. & Buckland R. A. (1973). Enzyme-containing Liposomes alleviate a Model

Gromelski, S. & Brezezinski, G. (2006). DNA condensation and interaction with zwittrionic phospolipids mediated by divalent cations*. Langmuir*, 22, 6293-6301, 0743-7463. Hacein-Bey-Abina, S. et al. (2003). LMO2-Associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. *Science*, 302, 415-419, 0036-8075. Harper, P. E.; Mannock, D.A.; Lewis, R.N.A.H.; McElhaney, R.N. & Gruner, S.M. (2001). X-

Harrington, J.J., Van Bokkelen, G., Mays, R.W., Gustashaw, K. & Williard, H.F. (1997).

Hoffman, R.M., Margolis, R.B. & Bergelson, L.D. (1978). Binding and entrapment of high molecular weight DNA by lecithin liposomes. *FEBS Lett*., 93, 365-368, 0014-5793. Kharakoz, D.P., Khusainova, R.S., Gorelov, A.V. & Dawson, K.A. (1999). Stoichiometry of

temperature-scanning ultrasonic study. *FEBS Lett*., 466, 27-29, 0014-5793. Klibanov, A.L., Maruyama, K:, Torchilin, V.P. & Huang, L. (1990). Amphipatic

Koiv, A., Palvimo, J. & Kinnunen, P.K. (1995). Evidence for ternary complex by histone H1,

Koltover, L., Salditt, T., Rädler, J.O. & Safinya*,* C.R. (1998). An inverted hexagonal phase of

Kostarelos, K. & Miller, A.D. (2005). Synthetic, self-assembly ABCD nanoparticles; a

(1-11), 1539-3755.

344, 1029-498X..

*Europhysics Letters*, 67, 669-675, 0295-5075.

resonance study. *Biophys. J*., 85, 4023-4040, 006-3495.

for Storage Disease. *Nature,* 244, 170-172, 0038-0836.

hexagonal phases. *Biophys. J*., 81, 2693-2706, 0006-3495.

polyethylenglycos effectively prolong the circulation time of liposomes. *FEBS,* 268, 235-237, 0014-5793.

281, 78-81, 0036-8075.

0306-0012.

artificial microchromosome. *Nat. Genet*., 15, 345-355, 1061-4036.

DNA and liposomes. *Biochemistry*, 34, 8018-8027, 0006-2960.

*Chem*., 12, 114-128, 1043-1802.

Structure of self-assembled liposome-DNA-metal complexes. *Phys. Rev. E*, 67, 11904

inverted hexagonal phase in self-assembled phospholipid-DNA-metal complexes.

transfer: synthesis and evaluation of their in vitro transfection efficiency. *Bioconj.* 

by fluorinated lipoplexes in the presence of a bile salt surfactant. *J.Gene Med*., 3, 338-

(2001c). In vitro cationic lipid-mediated gene delivery with fluorinated glycerophosphoethanolamine helper lipids. *Bioconj. Chem*., 12, 949-963, 1043-1802. Ge, M. & Freed J.H. (2003). Hydration, structure and molecular interactions in the

headgroup region of dioleoylphosphatidylcholine bilayers: an electron spin

Ray diffraction structures of some phosphatidylethanolamine lamellar and inverted

Formation of *de novo* centromeres and construction of first-generation human

dipalmitoylphosphatidylcholine-DNA interaction in the presence of Ca2+: a

cationic liposome-DNA complexes related to DNA release and delivery. *Science*,

structural paradigm for synthetic non-viral vectors. *Chem. Soc. Rev*., 34, 970-994,


Neutral Liposomes and DNA Transfection 347

Safinya, C.R., Ewert, K., Ahmad, A., Evans, H.M., Raviv, U., Needleman, D.J., Lin, A.J.,

Sessa, G. & Weissmann, G. (1968). Phospholipid spherules (liposomes) a model for

Shi, G., Guo, W., Stephenson, S.M. & Lee, R.J. (2002). Efficient intracellular drug and gene

cationic/anionic lipid combinations. *J. Control Rel.*, 80, 309–319, 0168-3659. Song, L.Y., Ahkong, Q.F.; Rong, Q., Wang, Z., Ansell, S., Hope, M.J. & Mui, B. (2002).

Szoka, F. & Papahadjopoulos, D. (1978). Procedure for preparation of liposomes with large

Szoka, F.C.,Jr., Xu, Y. & Zelphati, O. (1996). How are nucleic acids released in the cell from cationic-nucleic acid complexes. *J. Liposome Res*., 6, 567-587, 0898-2104. Tarahowsky, Y.S., Khusainova, R.S., Gorelov, A.V., Nicolaeva, T.I., Deev, A.A., Dawson,

DNA initiates polymorphic structural transitions in lecithin. *FEBS Lett*., 390, 133-136, 0014-

Tardi, P.G., Boman, N.L. & Cullis, P.R. (1996). Liposomal doxorubicin. *J. Drug Target.*, 4,

Tresset, G., Cheong, W.C.D., Tan, Y.L.S., Boulaire, J. & Lam, Y.M. (2007). Phospholipid

Tristram-Nagle, S.; Peytrache, H.I. & Nagle, J.F. (1998). Structure and interactions of fully hydrated dioleoylphosphatidylcholine bilayers. *Biophys. J*., 75, 917-925, 0006-3495. Turner, D.C. & Gruner, S.M. (1992). X-ray diffraction reconstruction of the inverted

Tyrrell, D.A., Heath, T.D., Colley, C.M. & Ryman, B.E. (1976). New aspects of liposomes.

Uhrikova, D., Hanulova, M.; Funari, S.S., Khusainova, R.S., Sersen, F., Balgavy, P. (2005).

Voinea, M. & Simionescu, M. (2002). Designing of intelligent liposomes for efficient delivery

Willard, H.F. (2000). Artificial Chromosomes Coming to Life. *Science*, 290, 1308-1309, 0036-

Wilschut, J., Düzgünes, N., Fraley, R. & Papahadiopoulos, D. (1980). Studies on the

based artificial viruses assembled by multivalent cations. *Biophys. J*., 93, 637-644,

hexagonal (HII) phase in lipid-water systems. *Biochemistry*, 31, 1340-1355, 0006-2960.

The structure of DNA-DOPC aggregates formed in presence of calcium and magnesium ions: a small-angle synchrotron X-ray diffraction study. *Biochim:* 

mechanism of membrane fusion: kinetics of calcium ion induced fusion of phosphatidylserine vesicles followed by a new assay for mixing of aqueous vesicle

biological membranes. *J. Lipid Res*., 9, 310-318, 0022-2275.

*Biochim. Biophys. Acta,* 1558, 1–13, 005-2736.

*Acad. Sci. USA*, 75, 4194-4198, 0027-8424.

*Biochim. Biophys. Acta*, 457, 259-302, 0005-2736.

of drugs. *J. Cell. Mol. Med*., 6, 465-474, 1582-1838.

contents. *Biochemistry*, 19, 6011-6021, 0006-2960.

*Biophys. Acta*, , 1713, 15-28, 005-2736.

A.K. & Ivanitsky, G.R. (1996).

129-140, 1061-186X.

5793.

0006-3495.

8075.

2573-2596, 1364-503X

Slack, N.L., George, C. & Samuel, C.E. (2006). Cationic liposome-DNA complexes: from liquid crystal science to gene delivery applications. *Phil. Trans. R. Soc. A*, 364,

delivery using folate receptor-targeted pH-sensitive liposomes composed of

Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes.

internal aqueous space and high capture by reverse-phase evaporation. *Proc. Natl.* 


Mui, H., Ahkong, Q.F., Chow, L. & Hope, M.J. (2000). Membrane perturbation and the

Newton, C., Pangborn, W, Nir, S. & Papahadjopoulos, D. (1978). Specificity of Ca2+ and Mg2+

Ostro, M.J., Giacomini, D., Lavelle, D., Paxton, W. & Dray, S. (1978). Evidence for traslation

Papahadjopoulos, D., Vail, W.J., Pangborn, W. & Poste, G. (1976). Studies on membrane

therapeutic efficacy. *Proc. Natl. Acad. Sci. USA*, 88, 11460-11464, 0027-8424. Pardridge, W.M. (2007). shRNA and siRNA delivery to the brain. *Adv. Drug Del. Reviews,* 59,

Pisani, M., Bruni, P., Conti, C., Giorgini, E. & Francescangeli, O. (2005). Self.-asembled

Pisani, M., Bruni, P., Caracciolo, G., Caminiti, R. & Francescangeli, O. (2006). Structure and

Pisani, M., Fino, V., Bruni, P., Di Cola, E. & Francescangeli, O. (2008). Metal induced cubic

Podgornik, R., Rau, D.C. & Parsegian, V.A. (1989). The action of interhelical forces on the

double-layer and hydration forces. *Macromolecules*, 22, 1780-1786, 0024-9297. Portis, A., Newton, C., Pangborn, W. & Papahadjopoulos, D. (1979). Studies on the

Rädler, J.O., Koltover, I., Salditt, T. & Safinya, C.R. (1997). Structure of DNA-Cationic

Roush, W. (1997). Molecular biology: counterfeit chromosomes for humans. *Science*, 276, 38-

Safinya, C.R., (2001). Structures of lipid-DNA complexes: supramolecular assembly and

interhelical packing regimes. *Science,* 275*,* 810-814, 0036-8075.

gene delivery. *Curr. Opin. Struct. Biol*., 11, 440-448, 0959-440X.

aqueous dispersions. *J. Phys. Chem. Letters B*, 112, 5276-5278, 1520-6106. Pisani, M., Fino, V., Bruni, P. & Francescangeli, O. (2009). DNA condensation into inverted

membrane structure. *Biochim. Biphys. Acta*, 506, 281-287, 0005-2736.

other divalent metals. *Biochim. Biophys. Acta*, 448, 265-283, 0005-2736. Papahadjopoulos, D.; Allen, T.M.; Gabizon, A.; Mayhew, E.; Matthay, K.; Huang, S.K.; Lee,

1467, 281-292, 0005-2736.

*Nature*, 274, 921-923, 0028-0836.

141–152, 0169-409X..

434, 315-323, 1542-1406.

132-143, 1542-1406.

39, 0036-8075.

*Chem. B*, 110, 13203-13211, 1520-6106.

*Biochemistry*, 18, 780-790, 0006-2960.

mechanism of lipid-mediated transfer of DNA into cells. *Biochim. Biophys. Acta*,

binding to phsphatidylserine vesicles and resultant phase changes of bilayer

of rabbit globin mRNA after liposome mediated insertion into a human cell line.

fusion. II. Induction in fusion in pure phospholipid membranes by calcium ions an

K.D.; Woodle, M.C.; Lasic, D.D.; Redemann, C. & Martin, F.J. (1991). Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor

liposome-DNA metal complexes related to DNA delivery. *Mol. Cryst. Liq. Cryst.*,

phase behavior of self-assembled DOPC-DNA-Metal Cation complexes. *J. Phys.* 

phase in poly(ethyleneglycol)-functionalized dioleoylphosphatidylethanolamine

hexagonal phase in aqueous dispersion of poly(ethylene)-functionalized dioleoylphosphatidylethanolamine and metal cations. *Mol. Cryst. Liq. Cryst.*, 500,

organisation of DNA double helices: fluctuation-enhanced decay of electrostatic

mechanism of membrane fusion: Evidence for an intermembrane Ca2+ phospholipid complex, synergism with Mg2+ and inhibition by spectrin*.* 

liposome complexes: DNA intercalation in multilateral membranes in distinct


**15** 

*Russia* 

**Non-Viral Gene Delivery Systems** 

**Structure-Activity Relationships** 

*1Moscow State Academy of Fine Chemical Technologies, Moscow* 

Michael A. Maslov1 and Marina A. Zenkova2

**Based on Cholesterol Cationic Lipids:** 

*2Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk* 

Gene therapy as an alternative to conventional medicine implies the elimination of the cause of a disease via the introduction of therapeutic nucleic acids (antisense oligonucleotide, or siRNA, or transgene expressing plasmid DNA, or aptamers, etc) into the cells of the organism (Blau & Springer, 1995; Lv et al., 2006; Karmali & Chaudhuri, 2007; Rayburn & Zhang R., 2008; and references in it). However, efficient delivery of genes at the physiological level into cells of living organism (''transfection'') is always more simple in theory than in practice. Both the therapeutic nucleic acids and cell membrane are negatively charged and therefore the spontaneous entry of naked nucleic acid inside cells is unlikely to be an efficient process. In other words, the development of clinically viable gene-targeted therapeutics and the design of safe and efficient gene delivery reagents (''transfection

Prior to reaching the nucleus, the therapeutic nucleic acids must overcome a number of biological barriers, in particular, the cellular, endosomal, and nuclear membranes. This process is achieved by the utilization of appropriate delivery systems, that protect the genetic material from the destructive action of enzymes and encourage their penetration into the intracellular space, transfer through the nuclear membrane, and further expression in the nucleus (Eliyahu et al., 2005). In addition, these delivery systems should be nontoxic,

The administration of genes for therapeutic purposes can be achieved using one of three different approaches. The first approach consists of a direct injection of naked nonprotected DNA into the cell resulting in a high level of transgene expression. The simplicity of this approach ensures it can be reasonably applied in a number of experimental protocols (Huang et al., Eds.; 2005). However, therapeutic application of unprotected naked nucleic acids is limited by the easily accessible organs (skin or muscles) for direct injection and is not applicable for systemic delivery due to a number of factors, the most important of which being extracellular nucleases. Gene-modified viruses and virus like particles represent the second approach for the cellular delivery of therapeutic nucleic acids. Viruses are efficient in transducing cells. However, the safety concerns regarding the use of viruses in humans

vectors'') are inseparable problems. (Templeton, Ed. 2010).

make non-viral delivery systems an attractive alternative.

non-immunogenic and biocompatible.

**1. Introduction** 

